Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0193302 Ultra Low Dose Doxepin And Methods Of Using The Same To Treat Sleep Disorders
The invention relates to doxepin, pharmaceutically acceptable salts and prodrugs of doxepin; compositions containing the same, and the use of any of the...
2018/0193301 Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals
The present invention pertains to the use for preventing or treating intestinal infections caused by gram-positive bacteria in animals of an antibacterial...
2018/0193300 GLYCERYL 3-HYDROXYBUTYRATES FOR TRAUMATIC BRAIN INJURY
A method of treatment of mild to moderate non-penetrating closed traumatic brain injury and mild to moderate TBI due to surgical intervention using...
2018/0193299 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability. The present invention further relates to a...
2018/0193298 COMPOSITION CONTAINING DIHOMO-GAMMA-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT
The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-.gamma.-linolenic acid, and which has the effect...
2018/0193297 ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS FOR USE AS MEDICINES
Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I,...
2018/0193296 LTB4 INHIBITION TO PREVENT AND TREAT HUMAN LYMPHEDEMA
Provided are therapeutic methods for treating a patient with lymphedema, or prophylactically treating an individual susceptible to lymphedema, by inhibiting...
2018/0193295 GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN...
In certain embodiments methods are provided for the therapeutic or prophylactic amelioration of one or more symptoms or disorders associated with metabolic...
2018/0193294 Dehydroabietic acid (DHAA) derivatives for use as ion channel openers
The present invention relates to derivatives of dehydroabietic acid useful in treatment of cardiac arrhythmia or a hyperexcitablity disease, such as epilepsy...
2018/0193293 FATTY ACID AMIDES FOR THE PREVENTION AND/OR TREATMENT OF STEATOHEPATITIS
The invention relates to the use of fatty acid amides with phenylalkylamines and of a pharmaceutical composition comprising at least one of these compounds in...
2018/0193292 PROCESS FOR PREPARATION OF CYSTEAMINE BITARTRATE
The present invention provides process for preparation of cysteamine bitartrate comprising reacting cysteamine or its salt with tartaric acid. The present...
2018/0193291 FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL
A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.
2018/0193290 TAPENTADOL NASAL COMPOSITION
Disclosed herein are pharmaceutical compositions for nasal administration comprising tapentadol, their preparation and their use in the treatment of pain.
2018/0193289 PROTOTYPICAL MOLECULAR PHARMACOLOGIC PROFILE OF FENDILINE AGAINSTNEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES
The present invention concerns the prototypical pharmacologic profile of 3,3-diphenyl-N-(1-phenylethyl) propan-1-amine (Fendiline), its enantiomers and its...
2018/0193288 METHODS AND COMPOSITIONS FOR TREATING SYMPTOMS ASSOCIATED WITH POST-TRAUMATIC STRESS DISORDER USING CYCLOBENZAPRINE
The present invention relates to methods for the treatment or prevention of symptoms associated with post-traumatic stress disorder, and related pharmaceutical...
2018/0193287 HOPS-BASED SUBSTANCE AND USE OF THE SUBSTANCE
The invention relates to a hops-based substance which comprises a mixture of (a) xanthohumol with the formula (1) and (b) at least one isomerized hops acid,...
2018/0193286 COMPOSITIONS COMPRISING A DENDRIMER-RESVERATROL COMPLEX AND METHODS FOR MAKING AND USING THE SAME
Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein....
2018/0193285 Rivastigmine Transdermal Compositions and Methods of Using the Same
Rivastigmine transdermal compositions are provided. Aspects of the transdermal compositions include an active agent layer which includes rivastigmine and a...
2018/0193284 TRANSDERMAL CREAM CONTAINING IMMUNOMODULATORS AND IMIQUIMOD
A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a...
2018/0193283 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE
The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer...
2018/0193282 IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF
Provided herein are implantable compositions and methods of use thereof for the local delivery of therapeutically active agents.
2018/0193281 COMPOSITION AND METHODS OF TREATMENT
The present invention relates to a composition comprising nanoparticles formed of a polymer and terbinafine, wherein the nanoparticles comprise particles in...
2018/0193280 Process and Apparatuses For Preparing Nanoparticle Compositions with Amphiphilic Copolymers and Their Use
This invention discloses a process for making nanoparticles of amphiphilic copolymers by flash precipitation. Nanoparticles may be of amphiphilic copolymer...
2018/0193279 NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT, BIODEGRADEABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY
The instant invention provides for novel cationic lipids of Formula A that can be used in combination with other lipid components such as cholesterol and...
2018/0193278 METHOD OF SYNTHESIS OF SILICA VESICLES AND USE THEREOF
The invention relates, in part, to a method of producing silica vesicles including under controlled conditions to thereby heavily influence the morphology and...
2018/0193277 GAMMA-HYDROXYBUTYRIC ACID GRANULES
A granule including a solid core on which is supported an active ingredient, said active ingredient being selected from gamma-hydroxybutric acid or one of its...
2018/0193276 DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE
Oral and parenteral dosage forms comprising halofuginone, including enteric-coated solid oral dosage forms, subcutaneous dosage forms and intravenous dosage...
2018/0193275 Oral Pharmaceutical Dosage Forms
Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.
2018/0193274 COMPOSITIONS FOR ILEO-JEJUNAL DRUG DELIVERY
The current invention affords new formulations which deliver reversible and irreversible covalent kinase inhibitors, in particular BTK inhibitors, into the...
2018/0193273 PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND DEXTROMETHORPHAN
This application provides an oral pharmaceutical composition in a solid form comprising amlodipine or a pharmaceutically acceptable salt thereof, a low dose...
2018/0193272 ORAL DELIVERY PRODUCT
An oral delivery product comprises a semi-permeable pouch designed for being placed in the oral cavity of a subject. The pouch encloses multiple solid...
2018/0193271 AN ORAL PHARMACEUTICAL DOSAGE FORM FOR THE DELIVERY OF A PEPTIDE AND/OR PROTEIN
The invention relates to an oral polymeric pharmaceutical dosage form which comprises a thermoresponsive eutectic composition which is solid at or about room...
2018/0193270 EXOSOMES FOR DELIVERY OF THERAPEUTIC AGENTS
The present invention provides exosomes as drug delivery vehicles, compositions comprising a therapeutic agent encapsulated within such exosomes, methods of...
2018/0193269 NANO-LIPOSOME CARRIER COMPOSITION CONTAINING HYBRID OF Cas9 PROTEIN AND GUIDE RNA
The present invention relates to nano-liposome carrier compositions that encapsulate a hybrid of a Cas9 protein and a guide RNA and methods of making and using...
2018/0193268 FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES
The disclosure describes a fusogenic liposome-coated porous silicon nanoparticles for high loading efficiency of anionic payloads (small molecules, dyes,...
2018/0193267 NANOLIPOSOMAL FORMULATION FOR TARGETING INTEGRIN-LINKED KINASE (ILK) WITH SMALL-INTERFERENCE RNA AND A METHOD...
The invention provides a nanoliposomal formulation that targets Integrin Linked Kinase (ILK) with small-interfering RNA (siRNA) in cisplatin-resistant ovarian...
2018/0193266 EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
An exosomal composition is provided that comprises a therapeutic agent encapsulated by an exosome. The therapeutic agent can be a phytochemical agent, a...
2018/0193265 COMPOSITIONS AND METHODS USING SAME FOR DELIVERING AGENTS INTO A TARGET ORGAN PROTECTED BY A BLOOD BARRIER
A method of delivering a pharmaceutical agent into a target organ protected by a blood barrier is provided. The method comprising administering to a subject in...
2018/0193264 WNT COMPOSITIONS AND METHODS FOR PURIFICATION
Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a...
2018/0193263 EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLASTIC LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE
The present invention relates to RANKL+ cellular vesicles isolated from osteoblastic lineage cells, optionally immortalised, their use for the therapeutic...
2018/0193262 LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron....
2018/0193261 METHOD FOR PREPARING HYDROGEL CONTAINING REDUCED GRAPHENE OXIDE
The present invention relates to a method for preparing a natural or synthetic polymer hydrogel loading graphene oxide or graphene, and to the selective and...
2018/0193260 BEVERAGE COMPOSITION COMPRISING NANOENCAPSULATED OXYGEN
The invention relates to a beverage composition comprising: water; oxygen bubbles; a surfactant in an amount of between about 0.1% (v/v) and about 0.5% (v/v);...
2018/0193259 CROMOLYN COMPOSITIONS FOR TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a...
2018/0193258 MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME
The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using...
2018/0193257 MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME
The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using...
2018/0193256 MICRONEEDLE ARRAY
An object of the present invention is to provide a microneedle array which is formed of a sheet portion and needles and is capable of achieving high drug...
2018/0193255 STABLE LIQUID FORMULATIONS OF MELPHALAN
The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also...
2018/0193254 MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES
The invention relates to a medicament containing a compound of general formula (I), where R.sub.1=independently, a straight or branched, saturated, singly- or...
2018/0193253 MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
A drug delivery device that includes a capsule for implantation into the body; the capsule further includes a reservoir for containing a substance such as a...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.